Here’s a note from my good friend, Thomas Dayspring, M.D., written for physicians (but, others are welcome to look on). Tom is one of the world’s most respected lipidologists (doctors who specializes in cholesterol problems):

MedPage is reporting that a secret test nabbed three riders for using a banned new form of erythropoietin. The drug is CERA (Mircera), a pegylated EPO developed by Roche that reached the European market earlier this year. It was approved by the FDA last November, but U.S. distribution has been stalled by a patent dispute with Amgen, another firm that markets EPO. 

My Take?

LifeNews.com is reporting that evangelical pro-life leader Dr. James Dobson may be prepared to change his position and endorse John McCain for president. Dobson has previously expressed a reluctance to support the Arizona senator over his pro-abortion rival Barack Obama but Dobson said that may change.

My Take?

Reuters and a number of other news agencies are reporting that the cholesterol fighter Vytorin s failed to meet the main goal of a study. They are also reporting that it is causing cancer. Are they telling you the truth?

My Take?

Reuters is reporting that a new rule requiring New York chain restaurants to post calorie information on their menus took effect on Friday, marking a first for a U.S. city. The move follows the city’s 2003 ban on public smoking and a ban on artery-clogging trans fats that began on July 1.

My Take?

The Associated Press is reporting that Singapore is considering legalizing kidney trading to help meet demand for kidney transplants, the city-state’s health minister said Monday.

My Take?